Bain Capital divested a 2.4% stake in Emcure Pharmaceuticals for Rs 563 crore through an open market transaction, reducing its holding to 6.31%. Emcure Pharma share price fell.

The floor price for the transaction has been set at ₹1,279.80 per share, representing a likely discount to the prevailing ...

Global investment firm Bain Capital on Friday divested a 2.4 per cent stake in Emcure Pharmaceuticals for Rs 563 crore through an open market transaction. Following the stake sale, shares of Emcure ...

At the end of the March quarter, BC Investments IV Ltd., the Bain Capital entity, held 8.68% stake in the company.

Shares of Emcure Pharma shall be in focus during the trading session on Friday as Bain Capital-affiliated entity BC ...

Shares of Emcure Pharmaceuticals slipped 2 per cent on Friday morning following a large block deal worth Rs 574 crore, in ...

Emcure Pharmaceuticals made its market debut on July 10, 2024. The shares of the Pune-based company have risen 27% against ...

Oak Re was one of just a couple of reinsurance start-ups to successfully launch into the post-Hurricane Ian hard market, and ...

Significant advances in innovative cooling technologies in past year lowered power usage effectiveness (PUE) in subtropical ...

Join us for a peaceful walk through Smith Rock State Park in Oregon, home to soaring 168-meter cliffs and one of the world’s ...

ONGC, Reliance, IEX, Emcure Pharmaceuticals, IndiGo, Godavari Bio, Techknowgreen, Signpost, Hazoor Multiple, Kaynes, BoB, ...

Blockchain isn’t a speculative detour; it’s a modern financial operating system. And for asset managers, it offers not just ...